XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy

NCT04639310 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision; Not a safety decision

Conditions

Epilepsy
Epilepsy in Children
Epilepsy; Seizure
Disease
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Epileptic Syndromes

Interventions

DRUG: XEN496
DRUG: Placebo

Sponsor

Xenon Pharmaceuticals Inc.